ABVC BioPharma, Inc (ABVC): Multiplikator Forward P/S
ABVC BioPharma adheres to ESG principles by optimizing resources and utilizing recycled packaging in botanical medicine. This forward price-to-sales chart visualizes market expectation trends, where the 43.70 metric indicates the status of current capitalization. Business success relies on the licensing of ADHD and depression treatments via royalties. The company is currently preparing the results of Phase II trials for its innovative developments.
Rincian metrik komprehensif lan analitis ABVC BioPharma, Inc (ABVC)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas ABVC BioPharma|ABVC - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal ABVC BioPharma|ABVC - Utang perusahaan|Utang-utang marang kapitalisasi buku ABVC BioPharma, Inc|ABVC - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan ABVC BioPharma|Likuiditas cepet abvcpharma.com
- indikator pendapatan resik lan kelipatan nilai:
ABVC - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep ABVC BioPharma|ABVC - Nilai perusahaan marang bathi resik|Pangali Forward P/E ABVC BioPharma Inc|ABVC - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ABVC BioPharma, Inc|ABVC - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan ABVC BioPharma|ABVC - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan abvcpharma.com|ABVC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep ABVC BioPharma
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:ABVC BioPharma, Inc. ABVC
The forward P/S reflects the ratio of market capitalization to expected revenue, allowing for an assessment of the premium paid for potential sales growth. By analyzing the forward P/S metric, an investor can identify the risk of overvaluation for ABVC BioPharma, given the dependence of revenues on volatile licensing deals and the company's limited working capital liquidity.
Analisis perusahaan pesaing
Multiplikator Forward P/S HLN (Haleon)|Multiplikator Forward P/S Kenvue Inc KVUE|Verona Pharma Corp - Multiplikator Forward P/S|MENS: Rasio rega marang prakiraan pendapatan|LGND (Ligand Pharmaceuticals) - Multiplikator forward rega marang pendapatan|AMRX (amneal.com) - Rasio rega marang prakiraan pendapatan|PRGO (Perrigo) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Alvotech S.A. (ALVO)|Multiplikator forward rega marang pendapatan LQDA (Liquidia Technologies)|GLPG (Galapagos Corp) - Rega forward marang dodolan|Multiplikator Forward P/S ANIP (ANI Pharmaceuticals)|mannkindcorp.com - Rasio rega marang prakiraan pendapatan|Amphastar Pharmaceuticals, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Pacira Pharmaceuticals PCRX|ARS Pharma (SPRY) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Theravance Corp (TBPH)|Rasio rega marang prakiraan pendapatan Aquestive Therapeutics|scPharma - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S TECX|TNXP (Tonix Pharma) - Rega forward marang dodolan|Multiplikator Forward P/S SXTC (China SXT Pharmaceuticals, Inc.)|Multiplikator Forward P/S Eupraxia Pharmaceuticals, Inc. EPRX|BHST - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan EXOZ (invizyne.com)|oramed.com (ORMP) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Entera Bio|HYFT (MindWalk) - Multiplikator Forward P/S|Multiplikator Forward P/S Cumberland Corp|Multiplikator Forward P/S QNTM|Multiplikator Forward P/S fibrogen.com (FGEN)|Multiplikator Forward P/S TELO (Telomir Pharmaceuticals, Inc.)|Rani Therapeutics Holdings - Rasio rega marang prakiraan pendapatan|SNYR: Multiplikator forward rega marang pendapatan|RLYB: Rasio rega marang prakiraan pendapatan|LEXX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan pulmatrix.com|Rasio rega marang prakiraan pendapatan Pheton Holdings Limited|Aptorum - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S LYRA|IBO (Impact BioMedical, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S TNFA (TNF Pharmaceuticals, Inc.)|Multiplikator Forward P/S cbdMD Inc. YCBD|PRFX - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CYTO (Altamira Therapeutics)|Lipella (LIPO) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan OptiNose Corp|PIRS (Pieris Pharmaceuticals) - Multiplikator Forward P/S|Multiplikator Forward P/S procapsgroup.com|Multiplikator forward rega marang pendapatan PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding Group) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan ACELYRIN, Inc. SLRN|TFF Pharmaceuticals, Inc (TFFP) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep
